On Friday, Applied Therapeutics Inc (NASDAQ: APLT) opened lower -5.49% from the last session, before settling in for the closing price of $8.92. Price fluctuations for APLT have ranged from $1.79 to $9.39 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 29.53% at the time writing. With a float of $86.00 million, this company’s outstanding shares have now reached $114.85 million.
The firm has a total of 25 workers. Let’s measure their productivity. In terms of profitability, gross margin is 312.01%, operating margin of 23434.23%, and the pretax margin is 48375.08%.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 25.12%, while institutional ownership is 79.92%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 29.53% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 2.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 90.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Analysing the last 5-days average volume posted by the [Applied Therapeutics Inc, APLT], we can find that recorded value of 1.67 million was lower than the volume posted last year of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 47.85%. Additionally, its Average True Range was 0.59.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 83.00%, which indicates a significant increase from 45.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.66% in the past 14 days, which was lower than the 106.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.18, while its 200-day Moving Average is $5.45. Now, the first resistance to watch is $8.83. This is followed by the second major resistance level at $9.24. The third major resistance level sits at $9.44. If the price goes on to break the first support level at $8.22, it is likely to go to the next support level at $8.02. Now, if the price goes above the second support level, the third support stands at $7.61.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are currently 114,267K shares outstanding in the company with a market cap of 968.19 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -119,760 K. Last quarter, the company’s sales amounted to 140 K and its income totaled 2,900 K.
